AU2002222557A1 - Interferon therapeutic effect-potentiating agents - Google Patents

Interferon therapeutic effect-potentiating agents

Info

Publication number
AU2002222557A1
AU2002222557A1 AU2002222557A AU2255702A AU2002222557A1 AU 2002222557 A1 AU2002222557 A1 AU 2002222557A1 AU 2002222557 A AU2002222557 A AU 2002222557A AU 2255702 A AU2255702 A AU 2255702A AU 2002222557 A1 AU2002222557 A1 AU 2002222557A1
Authority
AU
Australia
Prior art keywords
therapeutic effect
potentiating agents
interferon therapeutic
interferon
potentiating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002222557A
Inventor
Hirotoshi Hayasawa
Katsuaki Tanaka
Susumu Teraguchi
Koji Yamauchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of AU2002222557A1 publication Critical patent/AU2002222557A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002222557A 2000-11-29 2001-11-28 Interferon therapeutic effect-potentiating agents Abandoned AU2002222557A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000362813 2000-11-29
JP2000-362813 2000-11-29
PCT/JP2001/010383 WO2002043752A1 (en) 2000-11-29 2001-11-28 Interferon therapeutic effect-potentiating agents

Publications (1)

Publication Number Publication Date
AU2002222557A1 true AU2002222557A1 (en) 2002-06-11

Family

ID=18834024

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002222557A Abandoned AU2002222557A1 (en) 2000-11-29 2001-11-28 Interferon therapeutic effect-potentiating agents

Country Status (9)

Country Link
US (1) US20040013642A1 (en)
EP (1) EP1352657A4 (en)
JP (1) JPWO2002043752A1 (en)
KR (1) KR20030060931A (en)
CN (1) CN1596123A (en)
AU (1) AU2002222557A1 (en)
CA (1) CA2429793C (en)
NZ (1) NZ525597A (en)
WO (1) WO2002043752A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6657455B2 (en) * 2000-01-18 2003-12-02 Formfactor, Inc. Predictive, adaptive power supply for an integrated circuit under test
JP4592260B2 (en) * 2003-05-29 2010-12-01 雪印乳業株式会社 Lactoferrin composition
US20070191264A1 (en) * 2005-05-05 2007-08-16 Bristol-Myers Squibb Company, A Delaware Corporation Methods for inhibiting the growth of bacteria
WO2007001006A1 (en) 2005-06-29 2007-01-04 Nrl Pharma, Inc. Agent for ameliorating heavy metal-induced disorders, and medicinal composition, food and cosmetic containing the same
DE102005051366A1 (en) * 2005-10-25 2007-04-26 Degussa Gmbh Drug delivery systems
JP5264492B2 (en) * 2005-10-25 2013-08-14 エボニック デグサ ゲーエムベーハー Preparations containing hyperbranched polymers
EP1982698A1 (en) * 2007-04-18 2008-10-22 Evonik Degussa GmbH Preparations for controlled release of natural bioactive materials
EA013008B1 (en) * 2007-09-05 2010-02-26 Николай Евгеньевич Шатуновский Apolactoferrin compositions and methods of the use thereof for treating viral hepatitis c

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6351337A (en) * 1986-08-22 1988-03-04 Snow Brand Milk Prod Co Ltd Antitumor agent
JP3312946B2 (en) * 1993-03-04 2002-08-12 雪印乳業株式会社 Virus infection / growth inhibitor
JPH07188052A (en) * 1993-12-27 1995-07-25 Sanwa Kagaku Kenkyusho Co Ltd Interferon activity-enhancing agent and antivirus activity-enhancing composition containing the enhancing agent and interferon
US5814485A (en) * 1995-06-06 1998-09-29 Chiron Corporation Production of interferon-β (IFN-β) in E. coli
GB9813031D0 (en) * 1998-06-16 1998-08-12 Regen Biotech Limited Dietary supplement
CA2338884A1 (en) * 1998-07-30 2000-02-10 Morinaga Milk Industry Co., Ltd. Liver function ameliorating agents
JP2000325046A (en) * 1999-05-19 2000-11-28 Meiji Milk Prod Co Ltd Food or medicine for preventing and treating hepatitis
EP1245236A4 (en) * 1999-12-28 2004-09-22 Sumitomo Pharma Preventives and remedies for chronic hepatitis

Also Published As

Publication number Publication date
US20040013642A1 (en) 2004-01-22
EP1352657A1 (en) 2003-10-15
EP1352657A4 (en) 2004-06-16
JPWO2002043752A1 (en) 2004-04-02
NZ525597A (en) 2004-11-26
KR20030060931A (en) 2003-07-16
WO2002043752A1 (en) 2002-06-06
CN1596123A (en) 2005-03-16
CA2429793C (en) 2009-04-28
CA2429793A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2001252135A1 (en) Therapeutic agents
GB0012671D0 (en) Therapeutic agents
EP1296699A4 (en) Therapeutic agents - iii
GB0003397D0 (en) Therapeutic agents
GB0018473D0 (en) Therapeutic agents
AU2002222853A1 (en) Therapeutic compounds
GB0017256D0 (en) Therapeutic agents
GB0027561D0 (en) Therapeutic agents
GB0005789D0 (en) Therapeutic agents
GB0007907D0 (en) Therapeutic agents
GB0012214D0 (en) Therapeutic agents
GB0008696D0 (en) Therapeutic agents
GB0000564D0 (en) Therapeutic agents
GB0023610D0 (en) Therapeutic agents
GB0020721D0 (en) Therapeutic agents
AU2451500A (en) Therapeutic agents
GB0017518D0 (en) Therapeutic agents
AU2002222557A1 (en) Interferon therapeutic effect-potentiating agents
AU2001273903A1 (en) Therapeutic agents
AU5973600A (en) Therapeutic agents
AU2001275696A1 (en) Therapeutic agent
GB0017543D0 (en) Therapeutic agents
AU6150200A (en) Therapeutic agents
AU2001292897A1 (en) Novel therapy
AU5817400A (en) Therapeutic agents